ANI Pharmaceuticals (ANIP) PT Bumped to $70 at Roth Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
ANI Pharma (ANIP) Buys 22 Generic Drug Products from Teva (TEVA) in $25M Cash Deal
July 13, 2015 8:29 AM EDTANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals (NYSE: TEVA) for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension... More
